TABLE 3.

Commercially available IPG devices.

Device	Frequency	Pulsewidth	Mode	Ampltiude (Joohi, 2021)	Feature	Application
Medtronic Activa™ PC (Paff et al., 2020)	2–250 Hz	60–450 µs	CC or CV	0–25.5 mA 0–10.5 V	conditionally safe with MRI	Bilateral STN and Gpi Stimulation for PD, Unilateral Thalamic Stimulation for Ets,Unilateral or Bilateral stimulation of the Gpi or STN for treatment of chronic, drug refractory segmental or generalized dystonia
Medtronic Activa™ RC (Paff et al., 2020)					dual channel, rechargeable, conditionally safe with MRI
Medtronic Activa™ SC (Paff et al., 2020)	3–250 Hz				single channel, conditionally safe with MRI
Medtronic Percept™ PC (Joohi, 2021)	2–250 Hz	20–450 µs	CC	0–25.5 mA	closed loop feature (using local field potential as biomarker)
Abbott Infinity 5 (Paff et al., 2020)	2–240 Hz	20–500 µs	CC	0–12.75 mA	dual channel	Bilateral STN and GPi stimulation for PD and for bilateral thalamic stimulation for ETs
AbbottInfinity 7 (Paff et al., 2020)
Boston Scientific Vercise PC (Paff et al., 2020)	2–255 Hz	20–450—µs	CC	0.1–20 mA	dual channel	Bilateral STN stimulation for PD
Boston Scientific Vercise RC (Paff et al., 2020)			CC		dual channel, rechargeable
Boston Scientific Gevia (Paff et al., 2020)					dual channel, rechargeable, conditionally safe with MRI
PINS Medical G102 (Paff et al., 2020)	2–250 Hz	30–450—µs	CC or CV	0–25 mA;0–10 V	dual channel, remote wireless programming	PD, tremor, dystonia (Joohi, 2021)
PINS Medical G102R (Paff et al., 2020)					dual channel, rechargeable, remote wireless programming
PINS Medical G101A (Paff et al., 2020)					single channel, remote wireless programming
SceneRay 1180	1–1600 Hz	60–960 µs	—	—	dual channel remote wireless programming	—
Neuropace (Joohi, 2021)	1–333 Hz	40–1000 µs	CC	0–12.0 mA	closed loop feature (responsive neurostimulation), rechargeable (Shaikhouni, et al., 2015)	Drug-Resistant Epilepsy (DRE)